A detailed history of Retirement Systems Of Alabama transactions in Exelixis, Inc. stock. As of the latest transaction made, Retirement Systems Of Alabama holds 911,497 shares of EXEL stock, worth $30.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
911,497
Previous 731,476 24.61%
Holding current value
$30.3 Million
Previous $16.4 Million 43.91%
% of portfolio
0.09%
Previous 0.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

BUY
$21.96 - $27.6 $3.95 Million - $4.97 Million
180,021 Added 24.61%
911,497 $23.7 Million
Q2 2024

Jul 24, 2024

BUY
$20.34 - $23.73 $7.13 Million - $8.32 Million
350,740 Added 92.12%
731,476 $16.4 Million
Q1 2024

Apr 30, 2024

SELL
$20.17 - $23.93 $176,326 - $209,196
-8,742 Reduced 2.24%
380,736 $9.03 Million
Q4 2023

Feb 05, 2024

SELL
$19.25 - $24.13 $155,078 - $194,391
-8,056 Reduced 2.03%
389,478 $9.34 Million
Q3 2023

Nov 06, 2023

SELL
$19.04 - $22.74 $421,012 - $502,826
-22,112 Reduced 5.27%
397,534 $8.69 Million
Q2 2023

Jul 31, 2023

SELL
$18.17 - $20.48 $69,264 - $78,069
-3,812 Reduced 0.9%
419,646 $8.02 Million
Q1 2023

May 01, 2023

SELL
$16.3 - $19.41 $27,481 - $32,725
-1,686 Reduced 0.4%
423,458 $8.22 Million
Q4 2022

Feb 06, 2023

BUY
$14.96 - $17.39 $56,937 - $66,186
3,806 Added 0.9%
425,144 $6.82 Million
Q3 2022

Nov 04, 2022

SELL
$15.68 - $22.27 $18,565 - $26,367
-1,184 Reduced 0.28%
421,338 $6.61 Million
Q2 2022

Aug 03, 2022

BUY
$17.44 - $23.16 $128,637 - $170,828
7,376 Added 1.78%
422,522 $8.8 Million
Q1 2022

Apr 20, 2022

BUY
$17.03 - $22.67 $14,151 - $18,838
831 Added 0.2%
415,146 $9.41 Million
Q4 2021

Jan 20, 2022

BUY
$15.84 - $21.88 $101,154 - $139,725
6,386 Added 1.57%
414,315 $7.57 Million
Q3 2021

Nov 03, 2021

SELL
$16.3 - $21.14 $5,590 - $7,251
-343 Reduced 0.08%
407,929 $8.62 Million
Q2 2021

Jul 21, 2021

BUY
$17.95 - $25.56 $18,901 - $26,914
1,053 Added 0.26%
408,272 $7.44 Million
Q1 2021

Apr 15, 2021

BUY
$20.53 - $25.22 $58,079 - $71,347
2,829 Added 0.7%
407,219 $9.2 Million
Q4 2020

Jan 26, 2021

BUY
$18.39 - $24.8 $18,040 - $24,328
981 Added 0.24%
404,390 $8.12 Million
Q3 2020

Oct 20, 2020

BUY
$20.67 - $26.94 $67,363 - $87,797
3,259 Added 0.81%
403,409 $9.86 Million
Q2 2020

Jul 23, 2020

BUY
$16.46 - $27.42 $73,938 - $123,170
4,492 Added 1.14%
400,150 $9.5 Million
Q4 2019

Jan 28, 2020

BUY
$15.15 - $18.89 $28,906 - $36,042
1,908 Added 0.48%
395,658 $6.97 Million
Q3 2019

Oct 30, 2019

BUY
$17.68 - $22.65 $21,993 - $28,176
1,244 Added 0.32%
393,750 $6.96 Million
Q2 2019

Jul 09, 2019

BUY
$18.93 - $24.75 $34,263 - $44,797
1,810 Added 0.46%
392,506 $8.39 Million
Q1 2019

Apr 15, 2019

BUY
$19.6 - $24.76 $63,327 - $79,999
3,231 Added 0.83%
390,696 $9.3 Million
Q4 2018

Jan 10, 2019

BUY
$13.65 - $21.8 $33,920 - $54,173
2,485 Added 0.65%
387,465 $7.62 Million
Q3 2018

Oct 24, 2018

BUY
$15.87 - $22.4 $437,186 - $617,075
27,548 Added 7.71%
384,980 $6.82 Million
Q2 2018

Jul 17, 2018

BUY
$18.56 - $22.45 $6.63 Million - $8.02 Million
357,432 New
357,432 $7.69 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Retirement Systems Of Alabama Portfolio

Follow Retirement Systems Of Alabama and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.